Efficacy and safety of ninjinyoeito, Japanese Kampo medicine, on peripheral neuropathy and anemia induced by oxaliplati
Phase 2
- Conditions
- Colorectal cancer
- Registration Number
- JPRN-UMIN000014207
- Lead Sponsor
- Kanazawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1. Prior blood transfusion or G-CSF administration 2. Severe drug hypersensitivity 3. Peripheral neuropathy due to diabetes mellitus etc. 4. diabetes mellitus requiring insulin therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method